cells is c-Myc, an essential part of normal cell proliferative machinery (Eisenman, 2001), expressed at low levels throughout the cell cycle of proliferating, mitogen-stimulated somatic cells. In most tumor cells, Myc expression is deregulated, often markedly elevated, and no longer moter, have a well-described and demarked ontogeny,
and are dispersed throughout the pancreas amongst ous times. Virtually all ␤ cells in every islet were proliferating within 24 hr of c-MycER TAM activation, as indicated hundreds of spatially isolated islet colonies. This latter uniquely permits discrimination between direct effects by positive nuclear staining for the proliferation marker Ki-67. Proliferation was accompanied by significant, alof the transgene, expected to arise synchronously in all islets, and those due to stochastic secondary events, though incomplete, downregulation of insulin expression ( Figure 2A ). Continuous c-MycER TAM activation inexpected to emerge sporadically in isolated islets. Thus, the sporadic and focal tumorigenesis exhibited in the duced sustained islet cell proliferation (see below islets ( Figure 3A ) accompanied by normalization of the mitochondrial apoptotic pathway, which is the ultiblood glucose (Table 1) back to phenotypically normal, fully functional, insulinpositive, quiescent islets with normal levels of E cadhOur conclusion is that c-Myc must directly elicit in each ␤ cell those attributes, such as dedifferentiation, erin. We conclude from this that all the neoplastic paraphernalia we observe in the hyperplastic c-Myc/Bcl-x L angiogenesis, and invasion, that drive the observed tumor progression. In fact, such properties are consistent ␤ cell tumors, including dedifferentiation, invasion, and angiogenesis, remain completely dependent upon suswith some of the known activities described for c-Myc. For example, c-Myc antagonizes differentiation in multitained c-Myc activity for their support and maintenance. Interestingly, regression is also accompanied by subple cell lineages including ␤ cells, where we show it triggers rapid downregulation of insulin and PDX-1, both stantial infiltration of inflammatory cells that may be responsible for phagocytosis and clearance of apoptotic de facto markers of ␤ cell differentiation. A potential mechanism for this is suggested by the recent report and/or necrotic debris. Detailed kinetic analysis suggests that regression is that c-Myc may directly interfere with the action of the ␤ cell-specifying bHLH transcription factor Beta2/ mediated, at least in great part, by rapid collapse of vasculature that triggers death of excess ␤ cells. Such NeuroD by inhibiting its binding to a consensus E box element in the insulin promoter (Kaneto et al., 2002) . In rapid disassembly of vasculature is most consistent with a direct angiogenic role for c-Myc, as proposed above. drive tumor cell proliferation but, in addition, orchestrate many of the general attributes that expanding somatic However, it is also possible that ␤ cell growth arrest following Myc deactivation allows intrinsic antineoplascells will require to establish themselves within the soma. It remains to be seen whether such pleiotropic tic mechanisms such as the immune response to initiate regression. Another possibility is that ␤ cell redifferentiaproperties are peculiar to c-Myc or are shared by other factors that promote cell expansion, including oncotion renders supernumerary ␤ cells prey to such homeostatic forces as normally restrict ␤ cell mass. In this genic lesions in the Ras and E2F pathways. However, recent studies with other switchable oncogene transcontext, it is especially intriguing that regressing ␤ cell tumors return to normal islet size and morphology, illusgenic models reinforce the notion that incapacitating the driving oncogenic lesion can lead to expeditious trating that ␤ cell mass is stringently and adaptively regulated, at least within the pancreas.
regression Assay of Blood and Urinary Glucose and HL7 antibodies was demonstrated by preincubation with 2 g/ml All animals used in these studies were adults between 3 and 8 of their cognate peptide immunogen for 30 min at room temperature. months of age. For blood glucose measurement, mice were fasted Pan-Myc, HL7, E cadherin, and CD31 antibodies were found to for 4 hr and then placed into a heat chamber (32ЊC) for approximately label reliably only frozen tissue sections. Other antibodies were 10 min to induce vasodilation. Blood (0.2 ml) was collected from tail effective when used on both paraffin-embedded and frozen secveins, and glucose concentration was determined using a Glucotions, although Ki-67, Nkx6.1, and laminin antibodies required epiTrend 2 kit (Roche). Diastix test strips were used to determine urinary tope retrieval by microwaving paraffin-embedded sections at 700 glucose concentrations. W for 2 ϫ 10 min in 0.01 M citrate buffer (pH 6.0) (Vector) followed by immersion in cold water. 
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